Open Medicine
(Mar 2020)
LncRNA LINC00152 promotes laryngeal cancer progression by sponging miR-613
Zheng Xuesong,
Dong Su,
Sun Lele,
Xu Jialu,
Liu Jia,
Hao Rui
Affiliations
Zheng Xuesong
Department of Otolaryngology Head and Neck surgery, the Affiliated Hospital of Beihua University, Jilin132001, P.R. China
Dong Su
Departments of Anesthesia, the First Hospital of Jilin University, Changchun130021, P.R. China
Sun Lele
Department of Thyroid Surgery, The First Hospital of Jilin University, Changchun130021, P.R. China
Xu Jialu
Department of Thyroid Surgery, The First Hospital of Jilin University, Changchun130021, P.R. China
Liu Jia
Department of Thyroid Surgery, The First Hospital of Jilin University, Changchun130021, P.R. China
Hao Rui
Department of Infection, The Affiliated Hospital of Beihua University, Jilin132001, P.R. China
DOI
https://doi.org/10.1515/med-2020-0035
Journal volume & issue
Vol. 15,
no. 1
Abstract
Read online
Long noncoding RNA (lncRNA) LINC00152 (CYTOR) has been reported to be upregulated and to serve as a diagnostic biomarker in multiple types of cancers, including laryngeal squamous cell cancer (LSCC). However, the functional role and molecular mechanisms of LINC00152 in LSCC progression need to be further investigated.
Keywords
WeChat QR code
Close
